Natera Inc [NTRA] Investment Appeal on the Rise

Daniel Torres

In a filing, Natera Inc revealed its CO-FOUNDER Sheena Jonathan unloaded Company’s shares for reported $0.34 million on Dec 19 ’25. In the deal valued at $225.94 per share,1,500 shares were sold. As a result of this transaction, Sheena Jonathan now holds 22,532 shares worth roughly $5.3 million.

Then, Sheena Jonathan bought 4,500 shares, generating $990,000 in total proceeds.

Before that, Sheena Jonathan sold 3,070 shares. Natera Inc shares valued at $696,912 were divested by the CO-FOUNDER at a price of $227.01 per share. As a result of the transaction, Sheena Jonathan now holds 222,966 shares, worth roughly $52.49 million.

A number of analysts have revised their coverage, including BNP Paribas Exane’s analysts, who increased its forecast for the stock in late October from “an Underperform” to “a Neutral”. RBC Capital Mkts started covering the stock on March 13, 2025. It rated NTRA as “an Outperform”.

Price Performance Review of NTRA

On Tuesday, Natera Inc [NASDAQ:NTRA] saw its stock fall -0.07% to $235.4. Over the last five days, the stock has gained 3.52%. Natera Inc shares have risen nearly 48.90% since the year began. Nevertheless, the stocks have risen 48.70% over the past one year. While a 52-week high of $246.90 was reached on 12/08/25, a 52-week low of $125.38 was recorded on 04/07/25.

Levels Of Support And Resistance For NTRA Stock

The 24-hour chart illustrates a support level at 232.64, which if violated will result in even more drops to 229.87. On the upside, there is a resistance level at 237.58. A further resistance level may holdings at 239.75.

How much short interest is there in Natera Inc?

A steep rise in short interest was recorded in Natera Inc stocks on 2025-11-28, growing by 0.11 million shares to a total of 4.02 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 3.91 million shares. There was a rise of 2.78%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on January 23, 2025 when Barclays began covering the stock and recommended ‘”an Overweight”‘ rating along with a $200 price target.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.